製品番号: HY-134266

8-Bromo-AMP

Name: 8-Bromo-AMP
Brand: MedChemExpress
SKU: HY-134266
Price: 250.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(別名: 8-Bromoadenosine 5'-monophosphate; 8-Bromoadenylic acid)

1 Cited Publications

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

8-Bromo-AMP (8-Bromoadenosine 5'-monophosphate) is an AMP analog. 8-Bromo-AMP inhibits ADP-dependent glucokinase (ADPGK). 8-Bromo-AMP competitively inhibits ADPGK by binding to the nucleotide-binding site, inducing conformational changes, and acting on catalytic residues. 8-Bromo-AMP non-competitively inhibits rat adenylate kinase isozymes AK-M, AK II, and AK III. 8-Bromo-AMP inhibits T cell activation-induced ROS production and ROS-dependent IL-2 and IκB expression. 8-Bromo-AMP is used in research on cancer and myocardial ischemia-reperfusion injury.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度 : 98.78%
CAS 番号: 23567-96-6
分子式: C₁₀H₁₃BrN₅O₇P
分子量:426.12

保管条件:

Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month

8-Bromo-AMP 構造式

CAS 番号: 23567-96-6

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

HY-12306A
8-Bromo-cAMP

PKA Activator

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
- 体内実験
化学情報
Publications (1)
溶剤 & 溶解度
- 体外
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

^[1]

ADPGK

IL-2

IκB

AMPK アイソフォーム固有の製品をすべて表示 :

Interleukin Related アイソフォーム固有の製品をすべて表示 :

IKK アイソフォーム固有の製品をすべて表示 :

体外実験

Oxidative StressAnti-cancerCytokines & ChemokinesAdaptive ImmunityInnate ImmunityOthers

Oxidative Stress

Anti-cancer

8-Bromo-AMP (25-100 μM; 30 min) dose-dependently reduces PMA-triggered ROS generation in Jurkat T cells, with 100 μM decreasing ROS to approximately half of the initial value^[1].

Anti-cancer

Cytokines & Chemokines

Adaptive Immunity

Innate Immunity

8-Bromo-AMP (25-100 μM; 30 min) decreases PMA (Phorbol 12-myristate 13-acetate) (HY-18739)/Ionomycin (HY-13434)-induced expression of IL-2 and IκB in Jurkat T cells^[1].

Others

8-Bromo-AMP (8-Br-AMP) (1 mM) is a competitive inhibitor of hADPGK with a K_i of 270 μM^[1].
8-Bromo-AMP is a competitive inhibitor of phADPGK with a K_i of 160 μM^[1].
8-Bromo-AMP binds to wild-type phADPGK, phADPGK F272A, and hADPGK with K_d values of 16.85 μM, 17.44 μM, and 16.55 μM, respectively^[1].
8-Bromo-AMP (20 h) enhances β-adrenoceptor acquisition in primary rat hepatocyte cultures with an EC₅₀ of 47 μM^[3].
8-Bromo-AMP (30°C) competitively inhibits wheat seedling leaf 5'(3')-ribonucleotide phosphohydrolase with an apparent K_i of 9.1 μM^[4].
8-Bromo-AMP (24 h) almost completely inhibits PB-induced PBREM transactivation in the mouse liver^[6].
8-Bromo-AMP significantly attenuates PB-induced Cyp2b10 gene expression in the mouse liver^[6].
8-Bromo-AMP (8-Br-AMP) (10-100 μM) stimulates tracheary-element differentiation in Zinnia elegans mesophyll cell cultures in the absence of inductive concentrations of cytokinin^[9].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

RT-PCR^[1]

Cell Line:

Jurkat T cells
Concentration:

25 μM; 50 μM; 100 μM
Incubation Time:

30 min
Result:

Reduced the expression of IL-2 and IκB in PMA/ionomycin-induced Jurkat T cells.

体内実験

8-Bromo-AMP (20 mg/kg; i.p.; single injection) inhibits Phenobarbital-induced PBREM transactivation and Cyp2b gene expression in mouse liver in vivo, confirming that AMPK is required for Phenobarbital-induced CAR activation^[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Male
C3H/HeN mice (7 weeks of age)
^[6]
Dosage:

20 mg/kg
Administration:

i.p.; single injection
Result:

Almost completely inhibited the PB-induced increase in PBREM reporter gene activity.
Significantly attenuated the induction of Cyp2b gene expression by PB.

Related Protocols :

化学情報

CAS 番号 23567-96-6
性状 Solid
分子量 426.12
分子式 C₁₀H₁₃BrN₅O₇P
Color White to off-white
SMILES

O=P(O)(OC[C@@H]1[C@H]([C@H]([C@H](N2C(Br)=NC3=C(N=CN=C32)N)O1)O)O)O
別名

8-Bromoadenosine 5'-monophosphate; 8-Bromoadenylic acid
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (1)

All

Sort by:

Journal Impact Factor

Mil Med Res

ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression. [Abstract]

2023 Dec 12;10(1):64. PMID: 38082365

溶剤 & 溶解度

体外:

H₂O : 125 mg/mL (293.34 mM; Need ultrasonic)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.3468 mL

11.7338 mL

23.4676 mL

5 mM

0.4694 mL

2.3468 mL

4.6935 mL

10 mM

0.2347 mL

1.1734 mL

2.3468 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (300 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Grudnik P, et al. Structural basis for ADP-dependent glucokinase inhibition by 8-bromo-substituted adenosine nucleotide. The Journal of biological chemistry. 2018 Jul 13;293(28):11088-11099.

[2]. Lesiak K, et al. Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine. Journal of medicinal chemistry. 1986 Jun;29(6):1015-22.

[3]. Sandnes D, et al. 8-bromo-cAMP and 8-CPT-cAMP increase the density of beta-adrenoceptors in hepatocytes by a mechanism not mimicking the effect of cAMP. Pharmacology & toxicology. 1996 Jul;79(1):15-22.

[4]. Polya GM, et al. Regulation of a plant 5'(3')-ribonucleotide phosphohydrolase by cyclic nucleotides and pyrimidine, purine, and cytokinin ribosides. Proceedings of the National Academy of Sciences of the United States of America. 1974 Apr;71(4):1299-303.

[5]. Niles RM, et al. Differential growth inhibition in two human carcinoma cell lines by cyclic adenosine 5'-monophosphate analogs. Journal of the National Cancer Institute. 1979 Oct;63(4):909-11.

[6]. Shindo S, et al. A physiological role of AMP-activated protein kinase in phenobarbital-mediated constitutive androstane receptor activation and CYP2B induction. The Biochemical journal. 2007 Feb 01;401(3):735-41.

[7]. Hai TT, et al. Species- or isozyme-specific enzyme inhibitors. 7. Selective effects in inhibitions of rat adenylate kinase isozymes by adenosine 5'-phosphate derivatives. Journal of medicinal chemistry. 1982 Jul;25(7):806-12.

[8]. Shah MM, et al. The connexin43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: in vivo and in vitro studies. Molecular and cellular biochemistry. 2002 Sep;238(1-2):57-68.

[9]. Roberts AW, et al. Methylxanthines reversibly inhibit tracheary-element differentiation in suspension cultures of Zinnia elegans L. Planta. 1992 Mar;186(4):586-92.

[10]. Minelli A, et al. Activity of IMP- and AMP-preferring isoforms of 5'-nucleotidase from human seminal plasma with AMP analogues. Molecular genetics and metabolism. 1999 Jan;66(1):49-55.

[11]. Musi N, et al. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2001 May;280(5):E677-84.

[12]. Nakai T, et al. Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. Journal of cardiovascular pharmacology. 1996 Aug;28(2):264-70. [Content Brief]

[13]. Katsuki S, et al. Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol. 1977 Mar;13(2):330-41.

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
H₂O	1 mM	2.3468 mL	11.7338 mL	23.4676 mL	58.6689 mL
	5 mM	0.4694 mL	2.3468 mL	4.6935 mL	11.7338 mL
	10 mM	0.2347 mL	1.1734 mL	2.3468 mL	5.8669 mL
	15 mM	0.1565 mL	0.7823 mL	1.5645 mL	3.9113 mL
	20 mM	0.1173 mL	0.5867 mL	1.1734 mL	2.9334 mL
	25 mM	0.0939 mL	0.4694 mL	0.9387 mL	2.3468 mL
	30 mM	0.0782 mL	0.3911 mL	0.7823 mL	1.9556 mL
	40 mM	0.0587 mL	0.2933 mL	0.5867 mL	1.4667 mL
	50 mM	0.0469 mL	0.2347 mL	0.4694 mL	1.1734 mL
	60 mM	0.0391 mL	0.1956 mL	0.3911 mL	0.9778 mL
	80 mM	0.0293 mL	0.1467 mL	0.2933 mL	0.7334 mL
	100 mM	0.0235 mL	0.1173 mL	0.2347 mL	0.5867 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Bioz

8-Bromo-AMP

1 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

8-Bromo-AMP

MedChemExpress（MCE）の使用を引用している文献 8-Bromo-AMP

AMPK アイソフォーム固有の製品をすべて表示

Interleukin Related アイソフォーム固有の製品をすべて表示

IKK アイソフォーム固有の製品をすべて表示

生物活性

製品説明

IC₅₀ & Target

体外実験

体内実験

化学情報

Publications (1)

溶剤 & 溶解度

体外:

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Bioz

Keywords

最近チェックした製品

8-Bromo-AMP

MedChemExpress（MCE）の使用を引用している文献 8-Bromo-AMP

AMPK アイソフォーム固有の製品をすべて表示

Interleukin Related アイソフォーム固有の製品をすべて表示

IKK アイソフォーム固有の製品をすべて表示

生物活性

製品説明

IC50 & Target

体外実験

体内実験

化学情報

Publications (1)

溶剤 & 溶解度

体外:

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

8-Bromo-AMP 関連分類

HY-134266 関連分類

Bioz

Keywords

最近チェックした製品

IC₅₀ & Target